MedPath

Cardiometabolic Response to Sit-stand Workstations.

Not Applicable
Completed
Conditions
Sedentary Lifestyle
Interventions
Behavioral: Standing Desk
Behavioral: Traditional Desk
Registration Number
NCT02342301
Lead Sponsor
University of Prince Edward Island
Brief Summary

We aim to determine if changing a person's workstation from a traditional seated desk to a height adjustable "standing desk" for a period of approximately 3 months is associated with alterations in traditional measures of cardiometabolic risk.

Detailed Description

The present study will include 24 male and female participants 18 years of age and older who work in an office-based setting. To be included participants must be abdominally obese, defined as a waist circumference ≥ 88 cm for women, and 102 cm for men. All potential participants will be asked to come to the Human Performance Laboratory at University of Prince Edward Island and will be given an opportunity to ask questions about the study, and to read and sign the informed consent form. Once this has taken place, participants will have their waist circumference measured in order to determine whether they meet the above criteria. If not, the individual will be thanked for their time and told that they are not eligible to participate in the current study.

Lab Day 1 (baseline)

Once screening is complete, participants will have glycosylated hemoglobin checked via a simple finger prick and point-of-care analysis of a single drop of blood. (Funding dependent, a second drop of blood may be used to analyze the participant's blood lipid profile- as would be done at a typical doctor's office visit). Next we will measure the participants' resting metabolic rate, by having them lay on a hospital bed while we analyze the oxygen and carbon dioxide concentrations of the air they exhale. This will inform us as to the participant's baseline caloric needs. Blood pressure, height, weight, waist circumference and body composition will be determined following resting metabolic rate, prior to the determination of aerobic fitness using a sub-maximal exercise protocol (see below).

Augmentation Index:

Arterial stiffness will be determined using a Sphygmocor pulse wave applanation tonomoter (Atcor Medical). This device measures arterial pulse waves non-invasively through the skin at the wrist. We will use this same device to analyze the shape of the pulse wave, which will give us information about reflected pulse waves (and thus the stiffness of the arterial tree). The measure of arterial stiffness is non-invasive and pain-free and is taken using a pen-like tool pressed against the participant's skin to detect his or her pulse.

Prior to departing the lab, participants will be instructed on the use of an accelerometer-based activity monitor (20 min), which they will wear for 1 week prior to the desk intervention. During the activity monitor collection week, participants will also be instructed to wear a heart rate belt (non-invasive chest strap) for one day during working hours only (at least 4 hours of data collection) which will be analyzed after the strap is returned to the lab. Participants will then answer an online questionnaire about his/her current physical activity and sedentary behaviors. https://docs.google.com/forms/d/1fjz5ua47KzcdnhCAN7wCDGNbvy-tKSGgZKGGhIKSqQg/viewform?usp=mail_form_link . A similar questionnaire will be used for post- intervention follow-up with the tenses changed and questions about "anticipated" desk use altered to report on "actual" use (participants in the control group will be asked to answer "not applicable" for any questions related to standing desk use on the follow-up questionnaire).

Total participation Time (1.5 hr)

Once the baseline testing session is complete, participants will be randomly allocated to intervention or control groups (12 participants per group). Participants in the intervention group will be asked to complete the below intervention, while those in the control group will be asked to maintain their current lifestyle and office workstation throughout the study.

Intervention- the participant will be given a stand-up desk and asked to use it in place of their normal desk at work. Participants will again be given the activity and HR monitors to wear during the first and last 2 weeks of desk use.

Lab day 2 (post) - all measures from lab day 1 will be repeated as described above.

Aerobic Fitness- Aerobic fitness will be determined using a treadmill-based graded exercise test with analysis of expired gases. The test will consist of 2-3 increasingly more challenging stages of walking/running (through the addition of speed or incline) at a submaximal intensity. The heart rate and oxygen consumption data collected will be used to extrapolate the data to estimate maximal values. All aerobic fitness tests will be administered under the supervision of a Canadian Society for Exercise Physiology Certified Exercise Physiologist. Prior to any exercise all participants will be required to complete a Physical Activity Readiness Questionnaire (PAR-Q+) safe exercise participation screening form for known or suspected chronic disease risk factors (this tool is used for screening purposes only).

Resting metabolic rate will be determined using the same electrochemical analyzers (on the same metabolic cart) as the exercise measures, except a different flowmeter and gas collection system will be used (namely, we will use a canopy rather than a face mask). This will allow the participant to relax and rest normally without the need of having their nose and mouth covered by a rubber mask, as their entire head and shoulders will be contained within a canopy to collect gases. This system is identical to those used in-hospital.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
25
Inclusion Criteria
  • male and female participants
  • 18 years of age and older
  • work in an office-based setting.
  • abdominally obese, defined as a waist circumference ≥ 88 cm for women, and 102 cm for men.
Exclusion Criteria
  • glucose lowering medication
  • inability to stand or walk

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Standing DeskStanding DeskWill use standing desk for 3 months
Traditional DeskTraditional DeskWill use traditional desk for 3 months
Primary Outcome Measures
NameTimeMethod
Glycoslyated Hemoglobin (HbA1C)3 months

HbA1c will be measured at baseline and 3 months in both conditions in all participants using a bench-top analyzer.

Secondary Outcome Measures
NameTimeMethod
Sedentary Time3 months

Sedentary time will be measured at baseline and 3 months using an activPAL inclinometer.

Physical Activity3 months

Physical activity will be measured at baseline and 3 months using an activPAL inclinometer.

Fasting Glucose3 months

Fasting glucose will be measured at baseline and at 3 months using a bench top analyzer.

Augmentation Index3 months

Augmentation Index will be measured at baseline and 3 months using a Sphygmocor pulse wave applanation tonomoter.

Aerobic Fitness (VO2max)3 months

Aerobic Fitness will be measured at baseline and 3 months using a sub-maximal fitness test.

LDL Cholesterol3 months

LDL Cholesterol will be measured at baseline and at 3 months using a bench top analyzer.

Triglycerides3 months

Plasma triglycerides will be measured at baseline and at 3 months using a bench top analyzer.

Waist Circumference3 months

Waist circumference will be measured at baseline and 3 months at the level of the iliac crest.

HDL Cholesterol3 months

HDL Cholesterol will be measured at baseline and at 3 months using a bench top analyzer.

Trial Locations

Locations (1)

Human Performance and Health Research Lab, University of Prince Edward Island

🇨🇦

Charlottetown, Prince Edward Island, Canada

© Copyright 2025. All Rights Reserved by MedPath